中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2012年
36期
52
,共1页
曹德峰%郝冬琳%许元丰%王佳佳
曹德峰%郝鼕琳%許元豐%王佳佳
조덕봉%학동림%허원봉%왕가가
脑卒中%中经络%疏血通%血栓通
腦卒中%中經絡%疏血通%血栓通
뇌졸중%중경락%소혈통%혈전통
Stroke%In main and collateral channels%Shuxuetong injection%Xueshuantong
目的:探讨疏血通及血栓通治疗脑梗死后神经功能恢复的差异.方法:选取急性缺血性中风患者92例,随机分为治疗组和对照组各46例,治疗组采用疏血通注射液治疗,对照组采用血栓通注射液治疗,疗程为10~14 d,观察两组的疗效及不良反应.结果:治疗组其临床疗效明显优于对照组(P<0.05),治疗期间治疗组有不良反应发1例,对照组无不良反应发生.结论:疏血通在急性期改善神经功能缺损方面优于血栓通.
目的:探討疏血通及血栓通治療腦梗死後神經功能恢複的差異.方法:選取急性缺血性中風患者92例,隨機分為治療組和對照組各46例,治療組採用疏血通註射液治療,對照組採用血栓通註射液治療,療程為10~14 d,觀察兩組的療效及不良反應.結果:治療組其臨床療效明顯優于對照組(P<0.05),治療期間治療組有不良反應髮1例,對照組無不良反應髮生.結論:疏血通在急性期改善神經功能缺損方麵優于血栓通.
목적:탐토소혈통급혈전통치료뇌경사후신경공능회복적차이.방법:선취급성결혈성중풍환자92례,수궤분위치료조화대조조각46례,치료조채용소혈통주사액치료,대조조채용혈전통주사액치료,료정위10~14 d,관찰량조적료효급불량반응.결과:치료조기림상료효명현우우대조조(P<0.05),치료기간치료조유불량반응발1례,대조조무불량반응발생.결론:소혈통재급성기개선신경공능결손방면우우혈전통.
Objective: To explore the effects of Shuxuetong and Xueshuantong in the treatment of cerebral infarction and different safety. Method:92 cases of patients with acute ischemic stroke were randomly divided into 2 groups,46 cases in observation group and 46 cases in the control group. The observation group was treated with Shuxuetong injection,and the control group with Xueshuantong injection therapy. Course of treatment is 10 to 14 days. To observe curative effect and adverse reaction of the 2 groups. Result: Observation group was better than that of the control group(P<0.05). During treatment there was 1 case who had adverse reactions in the observation group,but the control group had non. Conclusion: Effect of Shuxuetong in the acute phase of improvement of nerve function defect is better than that of Xueshuantong.
